News Digest / Ticker: NMRA

Ticker: NMRA

05:14pm, Monday, May 12, 2025

Neumora Therapeutics Faces Significant Losses Amid Promising Clinical Trials and Strategic Collaborations

Neumora Therapeutics, Inc. (NASDAQ: NMRA) Company Overview: Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for neuropsychiatric disorders and neurodegenerative diseases, leveraging a precision neuroscience approach. Recent Devel...